Clinical Trials

Inclusion Criteria:

• An adult male patient who:
  • Is deemed eligible (or potentially/likely eligible) for PSMA-targeted radionuclide therapy by a Nuclear Medicine Physician or Radiologist in the Nuclear Medicine therapy practice, or by the Prostate Theranostic Tumor Board (PTuB).
  • Is acceptable to be potentially eligible for therapy but have a relative contraindication, such as a minor laboratory abnormality, and be on the list for discussion at the PTuB in the future.
  • Is acceptable to be eligible for PSMA-targeted radionuclide therapy in all regards except for having completed a PSMA-targeted PET scan showing PSMA-positive prostate cancer.
  • Is eligible to be documented in the medical record by the clinical practice.
  • Has not received a 68Ga-PSMA-11 PET/CT or PET/MR, or for whom a repeat 68Ga-PSMA-11 PET/CT exam is needed per the clinical practice to ensure eligibility.
  • Does not otherwise have access to a reimbursable clinical 68Ga-PSMA-11 PET scan.
  • An adult above the age of 18.

Exclusion Criteria:

• A patient who is:
  • Under the age of 18.
  • Unable to consent per Mayo guidelines.
  • Unable to lay still, or otherwise successfully complete the imaging exam.

Eligibility last updated 4/15/22. Questions regarding updates should be directed to the study team contact.